This study was conducted to evaluate the prevalence of androgenic alopecia, hair graying, DELC, and xanthoma in 366 IHD patients admitted to Kamkar and Shaheed Beheshti hospitals. Our findings suggest that these dermatological signs, especially baldness and hair whitening can be considered as CVD risk factors. Male pattern baldness in the study showed a high prevalence of 79.2% in men. Positive association between heart diseases and baldness has been demonstrated in some previous studies too (
10,
11). In a retrospective cohort study among 22071 male physicians relative risk (RR) CHD was 1.36 for severe vertex baldness, which remained unchanged after adjustment for risk factors such as age, diabetes mellitus, hypertension, and hyperlipidemia (
12). A meta-analysis on risk of CHD and alopecia in observational studies confirmed this association but only for vertex baldness (
13). Nevertheless, this relationship was not seen in some case-control and cross-sectional studies, which can be related to their design, selection and information biases. Cardiometabolic risk factors like hypertension, hyperlipidemia, fibrinogen, CRP, and insulin are higher in bald individuals (
10,
12,
14-
16), which are in contrast with our results. This discrepancy can be attributed to small sample size. As hormones like aldosterone and testosterone are greater in this group, peripheral sensitivity to androgens can explain the elevated levels of risk factors like blood pressure (
14).
Several studies have shown an association between premature hair whitening and CHD (
17-
20). In the present study, prevalence of this indicator was noticeably high. Schnohr et al. found RR of 1.9 for myocardial infarction (MI) in men with completely gray hair in comparison with men who had no gray hair; in women there was a similar but non-significant weak relationship (
17). It has also shown a positive relationship between risk factors that can be involved in this phenomenon through mechanisms like impaired DNA repair, inflammatory processes, and antioxidant reactions (
21-
26). However, some researchers could not find a correlation (
27), which can be explained by their poor methodology and lack of determination of diseases severity.
When disturbance in lipoprotein metabolism exists, lipid containing foam cells appear in dermis or tendons which led to premature detection of atherosclerosis (
28). In our study, the prevalence of xanthoma in IHD patients was 18.6%. Elevated levels of serum lipids, especially total cholesterol (TC) and LDL-c has been shown in patients with xanthomas (
29-
31). Even normolipidemic individuals with xanthelasma may have abnormal lipoprotein composition (
32). There is a relationship between this sign and IHD or MI even after adjustment for other CVD risk factors (
33). A meta-analysis showed that xanthoma in persons with familial hypercholesterolemia is associated with CVD risk (
34). Hazard/odds ratio of MI, IHD, and ischemic cerebrovascular disease was respectively 1.48, 1.39, and 1.69 in participants with xanthelasma irregardless of plasma lipids (
35). It can be explained by cholesterol leakage from vessels, its deposition in connective tissues, and its uptake by macrophages (
36). Civeira et al. also found that tendon xanthoma (TX) is associated with hypertension (
37).
There are numerous studies, which have demonstrated the very strong relationship between DELC and coronary artery atherosclerosis (CAA) (
38-
42). We found a 34.1% prevalence of DELC among our patients. Lichstein et al. showed that unilateral or bilateral DELC was significantly more common (47%) among patients hospitalized in an USA coronary-care unit than among age-matched control subjects (30%) (
39). There was a relationship between DELC, arterial hypertension, and hypercholesterolemia (
43). Degeneration of elastin, supplying ear lobe and heart by end arteries, skin aging, and shortened telomeres are some proposed mechanisms (
44). In conclusion, male pattern baldness, hair graying, xanthoma, and earlobe crease are associated with increased risk of ischemic heart disease. These dermatologic signs can be considered as CVD risk factors for screening.